SWOT Analysis for Tourmaline Bio Inc

Consistent Highest Return Stocks over Five Years
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
PEG lower than Industry PEG
Relative Outperformance versus Industry over 10 Years
Relative Outperformance versus Industry over 1 Month
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Stock gained more than 20% in one month
Stock with Low PE (PE < = 10)
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Top Losers
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Weak Momentum: Price below Short, Medium and Long Term Averages
Declining profits every quarter for the past 4 quarters
Top Losers